With the steadily decreasing cost of sequencing, low pass whole genome sequencing with imputation is gaining traction as a method of genotyping. The Element AVITI™ system can help even moderate throughput labs make the leap to this high information, cost-effective method with benefits including:
- Low per-run costs that make the many benefits of genotyping by sequencing accessible even for moderate throughput breeding programs.
- The ability to reduce both TAT and costs by decentralizing high-volume genotyping sequencing operations with the Element $200 Genome Program
- Seamless integration with the Gencove enterprise analytics platform for low pass imputation, simplifying genotype calling and report generation.
- High effective coverage stemming from a low duplication rate.
Blog
Resources
Poster: Low Pass Sequencing in Animals: Element Biosciences AVITI as a Useful Platform
View
Low-pass sequencing plus imputation using avidite sequencing displays comparable imputation accuracy to sequencing by synthesis while reducing duplicates - bioRxiv
Access
Gencove and Element Reduce Genomic Cost and Complexity Application Note
Download
Evaluating the AVITI™ for Use with the Gencove Low-Pass Sequencing and Analytics Platform
Watch